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INTRODUCTION
Bronchiectasis is a pathologic state of airway dilatation as
a result of continuous airway inflammation and destruction,
which forms a vicious circle with recurrent infection. Although
bronchiectasis is an uncommon disease and little is known
about its prevalence worldwide, the disease potentially cause
devastating illnesses, including repeated infections requiring
antibiotics, disabling productive cough, shortness of breath,
and occasional hemoptysis (1). While the pathogenesis of
bronchiectasis is not fully elucidated, it has been understood
that the destruction of the bronchial wall caused by contin-
ued extracellular matrix (ECM) damage is a major contribu-
tor to the development of permanent airway dilatation (1, 2).
The matrix-metalloproteinases are a family of proteolytic
enzymes that degrade the main protein components of the
extracellular matrices (ECMs) and may lead to continued
airway destruction when miscontrolled (3). Previous studies
showed that an excessive MMP activity plays an important
role in the pathogenesis of several respiratory diseases includ-
ing asthma, chronic obstructive pulmonary disease (COPD),
adult respiratory distress syndrome (ARDS), and pulmonary
fibrosis (4-7). Amongst them, MMP-8, in particular, is re-
ported to be overly expressed in the pulmonary tissue and
lavage fluid from patients with bronchiectasis to suggest its
potential role in the development of bronchiectasis (2, 8-
11). In the meantime, two single nucleotide polymorphisms
(-799C/T and  -381A/G) were identified from the promoter
region of the MMP-8 gene and reported to alter the promoter
activity and subsequent gene expression (12).
In this context, the present study aimed primarily at exa-
mining the association between the SNPs of MMP-8 and
the presence of bronchiectasis in a Korean population. More-
over, the frequencies of each genotype were reviewed in view
of the correlation of the polymorphism and the extent of dis-
ease, presence of microorganism colonization, and the degree
of pulmonary functional impairment, among the patient group.
MATERIALS AND METHODS
Determination of the sample size
Since the prevalence of SNP on -799C of MMP-8 promo-
ter is unknown in Korean population, estimation was made
according to the known value for a Western population, 70%
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Lack of Association between Matrix Metalloproteinase 8 Promoter
Polymorphism and Bronchiectasis in Koreans
The observation that human matrix metalloproteinase (MMP)-8 is over-expressed
in ectatic bronchi in patients with bronchiectasis suggests that polymorphisms alter-
ing the expression of MMP-8 may contribute to the susceptibility to development of
bronchiectasis. We evaluated the association between the presence of bronchiec-
tasis in a Korean population and two single nucleotide polymorphisms (SNPs) (-799C/
T and -381A/G) on the promoter region of the MMP-8 gene that are reported to
alter the promoter activity and thereby the gene expression. Genotyping through
polymerase chain reaction (PCR) and subsequent automatic sequencing was done
in 167 patients with bronchiectasis and their age-, sex-matched healthy controls to
reveal that only -799C/T is polymorphic among Koreans. In the patient group with
bronchiectasis, the frequency of -799C/C, C/T, and T/T genotypes were 41.9%,
49.7%, and 8.4%, respectively. A similar distribution was observed in the control
group: C/C (49.7%), C/T (43.1%), and T/T (7.2%) (p=0.36). In subgroup analysis,
no significant difference was observed among the patients according to; the extent
of disease (p=0.76), colonization of microorganisms (p=0.56), or association of
mycobacteria (p=0.17). From these results, we conclude that -799C/T on the pro-
moter region of MMP-8 lacks association with development of bronchiectasis in
Koreans.
Key Words : Bronchiectasis; Genetic Predisposition to Disease; Koreans; Matrix-metalloproteinase; Neutrophil
Collagenase; Single Nucleotide Polymorphism
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prevalence of 70%, alpha error of 0.10, beta error of 0.20,
and the expected difference being 15%. Substitution of these
parameters to the sample size table by Manchin et al. has
yielded the minimum sample size of 128 (13). 
Subjects
We prospectively enrolled 167 patients with bronchiecta-
sis diagnosed based on clinical manifestation and radiographic
findings on high-resolution computerized tomography (HR-
CT) or conventional computerized tomography of the chest.
The definition of ‘ectasis’ is as enlarged internal bronchial
diameter, where the bronchi appear larger than the accom-
panying artery. Patients with definite predisposing factors
of bronchiectasis such as primary ciliary dyskinesia, and var-
ious immune-deficient states were excluded from the study.
In addition, patients with diffuse panbronchiolitis or aller-
gic bronchopulmonary aspergillosis were also excluded. As
the control group, we enrolled 167 age- and sex-matched
healthy blood donors. All the patient and control partici-
pants were recruited from Seoul National University Hospi-
tal, and the data had been used for another previous study
(14). The protocol of this study was approved by the Insti-
tutional Review Board of Seoul National University Hospi-
tal, and informed consent was obtained before participation
from all subjects.
Genotyping of the three SNPs on MMP-8 promoter
Each blood sample drawn into EDTA tubes went through
a DNA extraction process using the Puregene DNA Isolation
Kit (Gentra Systems, Minneapolis, MN, U.S.A.) according
to the manufacturer’s protocol. On the basis of the human
MMP-8 promoter sequence deposited in GenBank (accession
no. AF059679), a promoter fragment was amplified with a
forward primer sequence of 5′ -CTGTTGAAGGCCTAGA-
GCTGCTGCTCC-3′ (corresponding to bp -872 to -846) and
a reverse primer 5′ -CATCTTCTCTTCAAACTCTACCC-3′
(corresponding to bp +74 to +96) yielding a 968-bp prod-
uct in accordance with the previous report (12). The PCR was
performed in a 50  L reaction volume containing 100 ng
genomic DNA, 0.5 pM of each primer, 0.2 mM dNTPs,
10x reaction buffer, 1.5 mM MgCl2 and 2.5 units of Taq-
polymerase (Invitrogen, Carlsbad, CA, U.S.A.) in the 9600
Gene Amp PCR Thermal Cycler. After purifying PCR prod-
ucts with a commercialized kit (QIAGEN, Valencia, CA,
U.S.A.), they were sequenced using an ABI 377 sequencer
(Applied Biosystems, Foster City, CA, U.S.A.) according to
the manufacturer’s protocol. 
Statistical analysis
Association between SNP on -799C/T and bronchiectasis
was tested using the two-tailed chi-square test, where the p
value below 0.05 being considered significant. Distribution
of the alleles and genotypes were examined to determine dif-
ferences among the patient and control groups and also in
the following aspects: according to the extent of bronchiec-
tasis, the presence of microorganism colonization, and the
association of mycobacteria. Odds ratios and 95% confidence
intervals were calculated to assess the relative risks conferred.
SPSS version 12.0 (SPSS Inc, Chicago, IL, U.S.A.) was used
for all statistical analyses. 
RESULTS
Demographics and clinical characteristics of the partici-
pants
A total of 167 patients with bronchiectasis (77 [46.1%]
females, median age 58 [23-80] yr) were recruited. Fifty-
three of them (37.1%) were current or ex-smokers, and 162
*n-a: non-applicable; 
� Several different bacteria were isolated in some
patients; 
�
Lingular segment was regarded as a separate lobe.
PFT, pulmonary function test; FEV1, forced expiratory volume in one
second; FVC, forced vital capacity.
Bronchiectasis
(N=167)
Controls
(N=167)
Age (median) 58 (23-80) 58 (22-80)
Sex (Male:Female) 90:77 90:77
History of smoking 53/167 (31.7%) n-a*
Non-smoker 114 (68.3%)
Ex-smoker 45 (26.9%)
<10 pack years 7
≥10 pack years 38
Current smoker 8 (4.8%)
History of respiratory diseases 162/167 (97.0%) n-a*
Measles 39 (23.4%)
Sinusitis 32 (19.2%)
Pertussis 18 (10.8%)
Pneumonia 11 (6.6%)
Tuberculosis 62 (37.1%)
Isolated organisms from sputa
� 45
� /119 (37.8%) n-a*
Streptococcus species 26 (21.8%)
Nontuberculous mycobacteria 24 (20.2%)
Pseudomonas aeruginosa 12 (10.1%)
Hemophilus influenzae 6 (5.0%)
Mycobacterium tuberculosis 3 (2.5%)
Other organisms 14 (11.8%)
PFT
FEV1 80.1±24.0%
FVC 91.3±19.0%
FEV1/FVC 63.4±14.3%
Radiographic extents
�
≤2 lobes 70 (41.9%)
≥3 lobes 97 (58.1%)
Table 1. The demographic and clinical characteristics of enrolled
patients
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had history of respiratory disease including tuberculosis (62
patients), measles (39 patients), pertussis (18 patients), and
sinusitis (19%). One hundred and nineteen of the patients
were collected for sputum samples, and various micro-organ-
ism were cultured in 45 of them (37%, of 119): Streptococ-
cus (26 patients), nontuberculous mycobacteria (24 patients),
and Pseudomonas aeruginosa (12 patients). As for the radiolog-
ical extent of disease, more than two lobes were involved in
58% (97/167) of the patients. The mean percentage of pre-
dicted FEV1 (forced expiratory volume in one second) and
FVC (forced vital capacity) were 80.1±24.0% and 91.3±
19.0%, respectively (Table 1).
Allele and genotype distribution in patients and controls
In an intention to detect other possible SNPs in Koreans,
we additionally screened every sequenced result. However,
no additional SNP was identified except -799C/T. In patients
with bronchiectasis, the frequency of -799C/C, C/T, and T/T
genotypes were 41.9%, 49.7%, and 8.4%, respectively. A
similar distribution was observed in the control group: C/C
(49.7%), C/T (43.1%), and T/T (7.2%). Although the dis-
tribution of genotypes were in Hardy-Weinberg equilibri-
um, the difference of genotype distribution as well as that
of allele’s was not statistically significant (p=0.36 and 0.21)
(Table 2).
Allele and genotype distribution in patients according to
various parameters
In subgroup analysis, no significant difference in terms of
genotypes or alleles was observed among the patients accord-
ing to: the extent of disease (p=0.76 for genotypes, 0.75 for
alleles), colonization of microorganisms (p=0.56 and 0.65)
or the association of mycobacteria (p=0.17 and 0.13).
*95% CI, 95% confidence interval.
Bronchiectasis
(N=167)
Controls
(N=167)
Odds ratio
(95% CI*)
p
value
Genotype distributions
C/C 70 (41.9%) 83 (49.7%) 0.36 1
C/T 83 (49.7%) 72 (43.1%) 0.73 
(0.47-1.14)
T/T 14 (8.4%) 12 (7.2%) 0.73
(0.31-1.67)
Allele distributions
C 223 (66.8%) 238 (71.3%) 0.21 1
T 111 (33.2%) 96 (28.7%) 0.81
(0.58-1.67)
Table 2. Distribution of alleles and genotypes among patients
with bronchiectasis and controls 
*95% CI, 95% confidence interval.
Unilateral
involvement
(N=50)
Bilateral
involvement
(N=117)
Odds ratio
(95% CI*)
p
value
Genotype distributions
C/C 21 (42%) 49 (41%) 0.76 1
C/T 26 (52%) 57 (48%) 0.94
(0.47-1.87)
T/T 3 (6%) 11 (9%) 1.57
(0.40-6.22)
Allele distributions
C 133 (68.6%) 90 (64.3%) 0.41 1
T 61 (31.4%) 50 (35.7%) 1.08
(0.66-1.79)
Table 3. Distribution of alleles and genotypes according to the
extent of bronchiectasis
*95% CI, 95% confidence interval.
Bronchie-
catsis with
pathogenic 
colonization
(N=45)
Bronchiecatsis
without 
colonization
(N=74)
Odds ratio
(95% CI*)
p
value
Genotype distributions
C/C 20 (44.4%) 27 (36.5%) 0.56 1
C/T 21 (46.7%) 42 (56.8%) 1.48
(0.68-3.23)
T/T 4 (8.7%) 5 (6.8%) 0.92
(0.22-3.89)
Allele distributions
C 61 (67.8%) 96 (64.9%) 0.65 1
T 29 (32.3%) 52 (35.1%) 1.14
(0.65-1.99)
Table 4. Distribution of alleles and genotypes according to the
bacterial colonization
*Presence of a history of previous pulmonary tuberculosis or isolation
of M. tuberculosis/nontuberculous mycobacteria from the sputa. BE,
bronchiectasis. 
�
95% CI, 95% confidence interval.
BE 
associated
with
Mycobac-
teria* (N=62)
BE not 
associated
with Mycobac-
teria (N=104)
Odds ratio
(95% CI
� )
p
value
Genotype distributions
C/C 34 (46%) 36 (38%) 0.17 1
C/T 36 (49%) 47 (50%) 1.23
(0.65-2.34)
T/T 3 (4%) 11 (11%) 3.46
(0.89-13.49)
Allele distributions
C 104 (71%) 119 (93%) 0.13 1
T 42 (28%)  69 (36%)  1.44
(0.90-2.29)
Table 5. Distribution of alleles and genotypes according to the
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DISCUSSION
This study showed no significant association between SNPs
on MMP-8 promoter gene and bronchiectasis in Koreans.
We studied two previously reported SNPs, and one of them
(-799C/T) was shown polymorphic among the population.
We searched for additional polymorphisms, only to observe
the presence of the previously shown one (-799C/T). No sig-
nificant difference was observed in either allelic or genotypic
distribution of -799C/T between the patients, and controls,
and this SNP showed no correlation with the presence of
bronchiectasis, disease extent, or mycobacterial diseases/infec-
tion as a cause of bronchiectasis in the study population. 
Assumable from being so-called the ‘orphan disease,’ little
is known about the pathogenesis of bronchiectasis despite
considerable recent progress made in the understandings in
other respiratory diseases. Several localized and generalized
impairments of host defense mechanisms have been proposed
as the causes for developing bronchiectasis, such as primary
ciliary dyskinesia, congenital immunodeficiency, and cystic
fibrosis (15, 16). However, the rarity of the above-mentioned
syndromes in Koreans suggests that other genetic factors may
contribute to the risk of bronchiectasis (17-19).
The matrix metalloproteinase family, ever since its initial
identification in the involuting tail of tadpoles by their abili-
ty to degrade collagen, has been studied for its physiological
roles and pathological contribution to tissue-remodeling
diseases. While several studies have implicated an excess
MMP activity in the pathogenesis of destructive pulmonary
pathology including COPD, asthma, and ARDS (4-7, 20),
MMP-8 in particular is reported to harbor stronger correla-
tion with one of the most destructive pathology, bronchiec-
tasis (2, 9). Meanwhile, there have been efforts to analyze
the MMPs’ association with obstetrical diseases where extra-
cellular matrix (ECM) remodeling is an important process
in several phases of human parturition. As a result, a specif-
ic genetic correlation between MMP-8 and preterm prema-
ture rupture of membranes was reported; the presence of
SNPs and their functional significance upon the gene expres-
sion (12). 
This study, inspired by the previous studies, had proposed
a role of the previously identified SNPs (12) on the patho-
genesis of bronchiectasis. Although the present study could
not reveal a significant correlation with those specific poly-
morphisms, MMPs still deserve attention, considering its
proposed central role in ECM turnover and the development
of several destructive pathologies. Alternative efforts to inves-
tigate on additional possible genetic association between
MMPs and bronchiectasis are needed.
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